Evogene (EVGN) Minority Interest (2018 - 2025)

Evogene has disclosed Minority Interest across 8 years of filings, most recently posting $12.1 million for Q4 2025.

• In Q4 2025, Minority Interest fell 25.98% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at $12.1 million (down 25.98% YoY), while the FY2025 annual figure was $12.1 million, down 25.98% from the prior year.
• Minority Interest came in at $12.1 million for Q4 2025 at Evogene, down from $15.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $17.4 million in Q3 2023 to a low of $6.4 million in Q1 2023.
• Average Minority Interest over 5 years is $12.5 million, with a median of $11.3 million recorded in 2021.
• Year-over-year, Minority Interest sank 30.37% in 2023 and surged 166.84% in 2024.
• Over 5 years, Minority Interest stood at $9.8 million in 2021, then dropped by 29.76% to $6.9 million in 2022, then jumped by 142.45% to $16.6 million in 2023, then declined by 2.06% to $16.3 million in 2024, then retreated by 25.98% to $12.1 million in 2025.
• Per Business Quant data, the three most recent Minority Interest figures were $12.1 million in Q4 2025, $15.9 million in Q2 2025, and $16.3 million in Q4 2024.